Quarterly report pursuant to Section 13 or 15(d)

Debt (Details)

v3.20.2
Debt (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Short-term Debt [Line Items]    
Total principal value $ 790,691  
Convertible multi-draw credit agreement - related party, net of discount $ 651,461 $ 387,070
Convertible debt | Emerald Health Sciences Inc    
Short-term Debt [Line Items]    
Conversion price $ 0.40  
Total principal value $ 2,014,500 2,014,500
Unamortized debt discount (1,358,687) (1,622,344)
Unamortized debt issuance costs (4,352) (5,086)
Carrying value of total convertible debt - related party 651,461 387,070
Convertible multi-draw credit agreement - related party, net of discount 450,000 0
Total carrying value of advances under the multi-draw credit agreement $ 1,101,461 $ 387,070